跳至主要内容
临床试验/IRCT2015111525031N2
IRCT2015111525031N2已完成未知

Evaluation of the prophylactic effect of tranexamic acid in von willebrand disease and glanzman thrombasthenia

Vice Chancellor for research of Arak University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 139 years(—)
性别
All

入选标准

  • All patients with a von Willebrand I, II, III and Glanzmann thrombasthenia which they records are included in Arak Amir-Kabir Hospital.;
  • Exclusion criteria:
  • (a)Patients who have a history of thrombosis;
  • (b)Patients who do not consent to the inclusion;
  • (c)Patients with hepatitis B or C;
  • (d)Patients with liver or renal dysfunction;
  • (e)Patients with local bleeding lesions such as hemangiomas or local wound;
  • (f)Younger than 2 years;
  • (g)Patients who can not tolerate the gastrointestinal drug;

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Arak University of Medical Sciences

相似试验